Multiparametric MRI for local staging in patients with suspected muscle-invasive bladder cancer: study protocol for a multicentre, non-inferiority randomised controlled trial (the BladParadigm study)
Introduction Muscle-invasive bladder cancer (MIBC) is an aggressive type of cancer. About 50% of patients will die from the disease within 5 years despite radical treatment. This implies that in many patients, the disease has already spread at the time of radical treatment, even though imaging shows...
Saved in:
Similar Items
-
TINF2 Gene Mutation in a Patient with Pulmonary Fibrosis
by: T. W. Hoffman, et al.
Published: (2016-01-01) -
Exploratory health economic analyses to support decisions within the innovation process in radiotherapy: Magnetic Resonance Linear Accelerator as a case study
by: Marike J. Ulehake, et al.
Published: (2025-06-01) -
Family history of pulmonary fibrosis impacts prognosis in patients with sarcoidosis
by: Thomas Planté-Bordeneuve, et al.
Published: (2025-02-01) -
Recent Insights into the Pathogenesis of Type AA Amyloidosis
by: J. C. H. van der Hilst
Published: (2011-01-01) -
From organ to cell: Multi-level telomere length assessment in patients with idiopathic pulmonary fibrosis.
by: Aernoud A van Batenburg, et al.
Published: (2020-01-01)